Healthcare costs attributable to the treatment of patients with spinal metastases: a cohort study with up to 8 years follow-up

Abstract

The index treatment accounts for almost half of lifetime health care costs from treatment initiation until death. As expected, lifetime healthcare costs are positively association with invasiveness of treatment.